These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection. Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. Sudo K; Watanabe W; Konno K; Sato R; Kajiyashiki T; Shigeta S; Yokota T Antimicrob Agents Chemother; 1999 Apr; 43(4):752-7. PubMed ID: 10103176 [TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model. Li L; Yu CH; Ying HZ; Yu JM J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991 [TBL] [Abstract][Full Text] [Related]
8. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. Ohol YM; Wang Z; Kemble G; Duke G PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560 [TBL] [Abstract][Full Text] [Related]
9. Tangeretin from Citrus reticulate Inhibits Respiratory Syncytial Virus Replication and Associated Inflammation in Vivo. Xu JJ; Liu Z; Tang W; Wang GC; Chung HY; Liu QY; Zhuang L; Li MM; Li YL J Agric Food Chem; 2015 Nov; 63(43):9520-7. PubMed ID: 26468759 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of Respiratory Syncytial Virus Infection on Different Week-ages BALB/c Mice]. Zhan L; Zhao M; Yi H; Zhang W; Cao J; Sun Y; Zhang L; Si J; Xia N; Zheng Z Bing Du Xue Bao; 2016 Jul; 32(4):411-6. PubMed ID: 29979541 [TBL] [Abstract][Full Text] [Related]
11. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus. Davis IC; Lazarowski ER; Hickman-Davis JM; Fortenberry JA; Chen FP; Zhao X; Sorscher E; Graves LM; Sullender WM; Matalon S Am J Respir Crit Care Med; 2006 Mar; 173(6):673-82. PubMed ID: 16387801 [TBL] [Abstract][Full Text] [Related]
12. Anti-Respiratory Syncytial Virus Activity of Chathuranga K; Kim MS; Lee HC; Kim TH; Kim JH; Gayan Chathuranga WA; Ekanayaka P; Wijerathne HMSM; Cho WK; Kim HI; Ma JY; Lee JS Viruses; 2019 Jul; 11(7):. PubMed ID: 31277257 [TBL] [Abstract][Full Text] [Related]
13. Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection. Cianci C; Genovesi EV; Lamb L; Medina I; Yang Z; Zadjura L; Yang H; D'Arienzo C; Sin N; Yu KL; Combrink K; Li Z; Colonno R; Meanwell N; Clark J; Krystal M Antimicrob Agents Chemother; 2004 Jul; 48(7):2448-54. PubMed ID: 15215093 [TBL] [Abstract][Full Text] [Related]
14. Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection. Davis IC; Lazarowski ER; Chen FP; Hickman-Davis JM; Sullender WM; Matalon S Am J Respir Cell Mol Biol; 2007 Oct; 37(4):379-86. PubMed ID: 17541010 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice. Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108 [TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection. Chen LF; Zhong YL; Luo D; Liu Z; Tang W; Cheng W; Xiong S; Li YL; Li MM J Ethnopharmacol; 2019 Oct; 242():111575. PubMed ID: 30391397 [TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo. Konno K; Miura M; Toriyama M; Motohashi S; Sawamura R; Watanabe W; Yoshida H; Kato M; Yamamoto R; Yasukawa K; Kurokawa M J Nat Med; 2013 Oct; 67(4):773-81. PubMed ID: 23344928 [TBL] [Abstract][Full Text] [Related]
19. Establishment of a lethal aged mouse model of human respiratory syncytial virus infection. Zhang K; Li C; Luo YS; Wen L; Yuan S; Wang D; Ho-Yin Wong B; Zhao X; Chiu MC; Ye ZW; Sun Z; Zhao H; Zhang X; Hu M; Yang D; Shuai H; Wang Y; He J; Bose ME; Henrickson KJ; Huang JD; Zheng B; Chu H; Zhou J Antiviral Res; 2019 Jan; 161():125-133. PubMed ID: 30503888 [TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Wendt CH; Hertz MI Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]